当前,在临床上正在探索威胁婴幼儿的川崎氏病的有效疗法。日本中京医院小儿心血管病科主任松岛正气,报告了15所医院和16个其他医疗单位进行对照研究的结果,确认大剂量丙种球蛋白疗法与迄今广泛应用的阿斯匹林疗法相比,其疗效较佳,既有明显的解热效果,而心脏的并发症也较少发生。 Currently, in clinical trials are exploring effective treatment of Kawasaki’s disease that threatens infants and young children. Japan’s Beijing Kyushu Hospital pediatric cardiovascular disease director Masashi Matsushima, reported 15 hospitals and 16 other medical units to control the results of the study to confirm the high dose of gamma globulin therapy and hitherto widely used aspirin therapy, Its better efficacy, both obvious antipyretic effect, and heart complications are less likely to occur.